ProPhase - שולי רווח תפעולי PRPH

ProPhase Labs, Inc. (PRPH) is implementing ESG standards across its laboratory systems, reducing its plastic footprint and strictly managing biohazardous waste disposal. The company's operating margin demonstrates current business efficiency, where 0.00 represents the current metric. Revenue is based on the diversification of tests and dietary supplements, while real growth is driven by Nebula Genomics genomic analysis sales, which offsets the impact of the pandemic-driven decline.
prophaselabs.com - פילוחים אנליטיים ומדדי מפתח (PRPH)

Fundamental analysis of ProPhase Labs, Inc. (PRPH) requires an assessment of cost management efficiency via the operating margin, which reflects the share of profit from core operations before taxes and interest. The operating margin trend demonstrates the company's ability to convert the scaling of diagnostic tests and laboratory automation into actual cash flow, confirming the resilience or degradation of the business model and the quality of the generated capital.